|
| Meda: FDA Approval Of The First Once-Daily Nasal Antihistamine |
4 Sep 09, 10:17 |
|
| The U.S. Food and Drug Administration (FDA) has approved Astepro (azelastine) nasal spray 0.15% for the treatment of the symptoms of seasonal and perennial allergic rhinitis. This new Astepro nasal spray 0.15% ("Astepro Once-Daily") is the first nasal antihistamine to offer convenient once-daily dosing for patients who suffer from seasonal allergies. |
| more |
|
